Wearable Devices to Monitor Seizures in Autoimmune Epilepsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-27

Study Completion Date

2023-11-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to search for reproducible changes in a wide range of physical signals, including heart rate, muscle tone and activity and EEG before and at the onset of seizures in patients with epilepsy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exploring Patient Impact & Value in Epilepsy Wearables for Seizure Monitoring

NCT06180538

Epilepsy

NOT_YET_RECRUITING

Development of a Practical, Minimally Invasive Seizure Gauge

NCT03745118

Epilepsy

COMPLETED NA

Seizure Detection and Warning System in Epilepsy Patients

NCT02555410

Epilepsy Generalized Tonic-Clonic Seizures

COMPLETED

Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking

NCT06275685

Epilepsy; Seizure

RECRUITING NA

Seizure Detection and Warning System for Epilepsy Patients

NCT01874600

Epilepsy

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autoimmune Epilepsy Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autoimmune Epilepsy with Biosensors

Subjects with suspected autoimmune epilepsy will wear biosensors on wrist or upper arm during the at home monitoring period.

Group Type EXPERIMENTAL

Biosensor

Intervention Type DEVICE

Noninvasive wearable biosensor device worn on the primary affected wrist or upper arm for as much time as is feasible for 7-10 days

Healthy Controls with Biosensors

Neurologically normal adult healthy controls will wear biosensors on wrist or upper arm during the at home monitoring period.

Group Type ACTIVE_COMPARATOR

Biosensor

Intervention Type DEVICE

Noninvasive wearable biosensor device worn on the primary affected wrist or upper arm for as much time as is feasible for 7-10 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biosensor

Noninvasive wearable biosensor device worn on the primary affected wrist or upper arm for as much time as is feasible for 7-10 days

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with or suspected of having autoimmune epilepsy.
* Normal controls - cognitively normal subjects without epilepsy

Exclusion Criteria

• Cognitive or psychiatric condition rendering patient unable to cooperate with data collection or manage and recharge smart watch and tablet computer devices. Presence of open or healing wounds near monitoring sites (infection risk).

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes